Journal profile · Hematology
GEMATOLOGIYA I TRANSFUZIOLOGIYA
ISSN 0234-5730 · Izdatel'stvo Meditsina · RUSSIA · Bimonthly · Founded 1983
GEMATOLOGIYA I TRANSFUZIOLOGIYA: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.16; fully open access; review over 12 weeks (community reports); community-reported acceptance: easy; 40 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
GEMATOLOGIYA I TRANSFUZIOLOGIYA is published by Izdatel'stvo Meditsina and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies and Military Technology and Strategies, together about 75.6% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
The journal publishes original theoretical and clinical studies, lectures, reviews, and practical notes concerning various problems of hematology and clinical and industrial transfusion. The journal provides information on the etiology, pathogenesis, diagnosis and treatment of blood disorders as well as on related non-hematological conditions (internal diseases, poisoning, exposure to ionizing radiation etc.).
Source: LetPub
Research area (LetPub): Hematology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Legal and Regulatory AnalysisSocial Sciences25.2%
- Linguistic, Cultural, and Literary StudiesSocial Sciences25.2%
- Military Technology and StrategiesEngineering25.2%
- Chronic Lymphocytic Leukemia ResearchMedicine2.2%
- Chronic Myeloid Leukemia TreatmentsMedicine2.1%
- Lymphoma Diagnosis and TreatmentMedicine1.7%
- Platelet Disorders and TreatmentsMedicine1.7%
- Acute Myeloid Leukemia ResearchMedicine1.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.16LetPub ·
- CiteScore 2026-06
- 1LetPub ·
- SJR 2026-06
- 0.14LetPub ·
- SNIP 2026-06
- 0.35LetPub ·
- h-index
- 4LetPub ·
- h-index
- 10OpenAlex ·
- i10-index
- 12OpenAlex ·
- 2-year mean citedness
- 0.44OpenAlex ·
- Self-citation rate
- 50%LetPub ·
- Share of gold OA articles
- 83.33%LetPub ·
Volume
- Articles per year
- 40LetPub ·
Articles by year OpenAlex count · 1,043 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 20 | 0 |
| 2025 | 40 | 40 | 12 |
| 2024 | 38 | 38 | 31 |
| 2023 | 40 | 40 | 62 |
| 2022 | 43 | 43 | 139 |
| 2021 | 39 | 39 | 90 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Izdatel'stvo Meditsina
- Country or region
- RUSSIA
- Language
- Russian
- Frequency
- Bimonthly
- Founded
- 1983
- ISSN
- 0234-5730
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about GEMATOLOGIYA I TRANSFUZIOLOGIYA
What CAS zone is GEMATOLOGIYA I TRANSFUZIOLOGIYA in?
In the 2025 upgraded edition of the CAS Journal Ranking, GEMATOLOGIYA I TRANSFUZIOLOGIYA is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of GEMATOLOGIYA I TRANSFUZIOLOGIYA?
The latest impact factor listed by LetPub is 0.16; CiteScore 1, h-index 10.
How long does peer review take at GEMATOLOGIYA I TRANSFUZIOLOGIYA?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index GEMATOLOGIYA I TRANSFUZIOLOGIYA?
According to LetPub and DOAJ records, GEMATOLOGIYA I TRANSFUZIOLOGIYA is indexed in SCIE and Scopus.
Is GEMATOLOGIYA I TRANSFUZIOLOGIYA open access, and what is the APC?
GEMATOLOGIYA I TRANSFUZIOLOGIYA is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .